Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

15 Oct 2008 07:00

RNS Number : 8515F
Xaar PLC
15 October 2008
Β 

ο»Ώ

FOR IMMEDIATE RELEASE

15 OctoberΒ 2008

Xaar plc

INTERIM MANAGEMENTΒ STATEMENT

Xaar plc ("Xaar"Β or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 July 2008 to 30 September 2008.Β 

Against an increasingly uncertain financial, economic and trading background, Xaar has maintained its strong balance sheet with cash at 30 September 2008Β ofΒ Β£10.1m (30 June 2008: Β£10.7m) after payment of the interim dividend of Β£0.6m. Total debtΒ at 30Β September 2008 wasΒ Β£0.7m (30 June 2008: Β£0.7m). This cash neutral positionΒ during the quarterΒ reflects the prudent management of the Group's cost base and discretionary expenditure,Β ensuringΒ a solid platform for theΒ future.

Sales of Xaar'sΒ establishedΒ Platform 1Β ("P1")Β products toΒ China,Β which saw a significant decline towards the end of Q2,Β stabilisedΒ duringΒ Q3 but at a levelΒ which is lower than inΒ previous years.Β Β Sales ofΒ P1 products to other regions and sales of Platform 2Β ("P2")Β andΒ PlatformΒ 3Β ("P3")Β products remain on track.Β Β With revenues in Q3 lower than planned, and production levels in line withΒ this lowerΒ demand,Β marginsΒ and profitsΒ were belowΒ plan. The Board expects an improved performance inΒ Q4Β but,Β in light ofΒ the outlook for the global economy,Β must remain cautious.

TheΒ GroupΒ hasΒ alreadyΒ implementedΒ a series of cost saving measures, theΒ benefits of which will be seenΒ in 2009.

NewΒ launchesΒ byΒ our OEM (Original Equipment Manufacturer) customersΒ continue.Β Printers usingΒ Xaar'sΒ newΒ P1Β products have been introduced into the established graphics market; a further four new printing machines based onΒ P3Β technology were releasedΒ in industriesΒ including label printing and ceramic tile printing.Β 

With a robust cash position, prudent management and excellent new technologies theΒ BoardΒ remains confident in the future of the business.

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance DirectorΒ 

Β 

Β 

Bankside Consultants:

Β 

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBLBDGLGBGGIS
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.